$50.43
-0.18-0.36%
At Close: -
$50.43
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Ionis Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ionis Pharmaceuticals using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
IONS | Ionis Pharmaceuticals | -$0.41 | -$0.95 | — | — | $188.00M | $146.02M | — | — | 08/07/2024 | Get Alert |
IONS | Ionis Pharmaceuticals | -$0.68 | -$1.03 | -$0.77 | 25.24% | $131.00M | $138.28M | $119.00M | -13.94% | 05/07/2024 | Get Alert |
IONS | Ionis Pharmaceuticals | -$1.18 | -$0.83 | -$0.06 | 92.77% | $152.00M | $174.76M | $325.00M | 85.97% | 02/21/2024 | Get Alert |
IONS | Ionis Pharmaceuticals | -$0.16 | -$1.07 | -$0.85 | 20.56% | $160.00M | $132.90M | $144.00M | 8.35% | 11/02/2023 | Get Alert |
IONS | Ionis Pharmaceuticals | -$0.56 | -$0.90 | -$0.41 | 54.44% | $134.00M | $138.83M | $188.00M | 35.42% | 08/09/2023 | Get Alert |
IONS | Ionis Pharmaceuticals | -$0.27 | -$0.91 | -$0.68 | 25.27% | $142.00M | $128.12M | $131.00M | 2.25% | 05/03/2023 | Get Alert |
IONS | Ionis Pharmaceuticals | $1.55 | -$0.92 | -$1.18 | -28.26% | $440.00M | $158.65M | $152.00M | -4.19% | 02/22/2023 | Get Alert |
IONS | Ionis Pharmaceuticals | -$0.34 | -$0.74 | -$0.16 | 78.38% | $133.00M | $143.84M | $160.00M | 11.23% | 11/09/2022 | Get Alert |
IONS | Ionis Pharmaceuticals | -$0.26 | -$0.62 | -$0.56 | 9.68% | $126.00M | $140.70M | $134.00M | -4.76% | 08/09/2022 | Get Alert |
IONS | Ionis Pharmaceuticals | -$0.32 | -$0.71 | -$0.27 | 61.97% | $112.00M | $125.21M | $142.00M | 13.41% | 05/04/2022 | Get Alert |
IONS | Ionis Pharmaceuticals | $0.81 | $0.28 | $1.55 | 453.57% | $290.00M | $259.15M | $440.00M | 69.79% | 02/24/2022 | Get Alert |
IONS | Ionis Pharmaceuticals | -$0.22 | -$0.51 | -$0.34 | 33.33% | $160.00M | $158.38M | $133.00M | -16.02% | 11/03/2021 | Get Alert |
IONS | Ionis Pharmaceuticals | -$0.23 | -$0.58 | -$0.26 | 55.17% | $146.00M | $129.94M | $126.00M | -3.03% | 08/04/2021 | Get Alert |
IONS | Ionis Pharmaceuticals | -$0.35 | -$0.53 | -$0.32 | 39.62% | $133.00M | — | $112.00M | — | 05/05/2021 | Get Alert |
IONS | Ionis Pharmaceuticals | $1.33 | $0.28 | $0.81 | 189.29% | $494.00M | $274.48M | $290.00M | 5.65% | 02/24/2021 | Get Alert |
IONS | Ionis Pharmaceuticals | $0.18 | -$0.09 | -$0.22 | -144.44% | $168.00M | $182.14M | $160.00M | -12.16% | 11/04/2020 | Get Alert |
IONS | Ionis Pharmaceuticals | -$0.01 | -$0.27 | -$0.23 | 14.81% | $164.00M | $148.87M | $146.00M | -1.93% | 08/05/2020 | Get Alert |
IONS | Ionis Pharmaceuticals | $0.62 | -$0.12 | -$0.35 | -191.67% | $297.00M | $161.42M | $133.00M | -17.61% | 05/06/2020 | Get Alert |
IONS | Ionis Pharmaceuticals | $0.19 | $0.93 | $1.33 | 43.01% | $192.11M | $409.28M | $494.00M | 20.70% | 02/26/2020 | Get Alert |
IONS | Ionis Pharmaceuticals | -$0.03 | -$0.33 | $0.18 | 154.55% | $145.40M | $153.37M | $168.00M | 9.54% | 11/06/2019 | Get Alert |
IONS | Ionis Pharmaceuticals | -$0.05 | -$0.27 | -$0.01 | 96.30% | $117.75M | $145.57M | $164.00M | 12.66% | 08/07/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-07 | $-0.77 | $-1.03 | 25.2 % |
Dec 2023 | 2024-02-21 | $-0.06 | $-0.83 | 92.8 % |
Sep 2023 | 2023-11-02 | $-0.85 | $-1.07 | 20.6 % |
Jun 2023 | 2023-08-09 | $-0.41 | $-0.90 | 54.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-07 | $119.00M | $138.28M | -13.9 % |
Dec 2023 | 2024-02-21 | $325.00M | $174.76M | 86.0 % |
Sep 2023 | 2023-11-02 | $144.00M | $132.90M | 8.35 % |
Jun 2023 | 2023-08-09 | $188.00M | $138.83M | 35.4 % |
Ionis Pharmaceuticals (IONS) is scheduled to report earnings on August 7, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.
The Actual EPS was $-0.77, which beat the estimate of $-1.03.
The Actual Revenue was $119M, which missed the estimate of $138.3M.
Browse earnings estimates, EPS, and revenue on all stocks.